Audience
Cardiologists in search of a tool to assess coronary artery disease and optimize patient treatment plans
About HeartFlow
HeartFlow's non-invasive personalized cardiac test provides unprecedented visualization of each patient's coronary arteries, enabling physicians to create more effective treatment plans for their patients. The HeartFlow FFRCT Analysis starts when a patient undergoes a standard coronary computed tomography scan at a hospital or imaging center. The CT images are securely uploaded to our cloud. Next, we use advanced algorithms incorporating artificial intelligence to build a personalized, digital model of that patient’s coronary arteries. Our team of highly trained analysts then inspects this model, making any needed edits. Once this patient-specific model is completed, the HeartFlow pathway applies physiologic principles and computational fluid dynamics to compute the blood flow and FFRCT values at every point in the model. Throughout the process, we follow rigorous and well-established protocols to ensure consistent processing for every patient.
Other Popular Alternatives & Related Software
Medis Suite XA
Medis Suite XA is our solution for X-Ray angiography. With a workflow based on 30+ years of experience in cardiovascular image analysis, Medis Suite XA is a complete package that provides various modules including a highly practical viewer, various coronary and vascular analyses that allow for anatomical evaluation of the arteries, various analyses for both ventricles, as well as integrated reporting. The analysis of coronary and peripheral vessels (QCA and QVA) in angiograms. The analysis of left and right ventriculograms (QLV and QRV). Innovative QFR® analysis, a measure of the functional significance of lesions, without the need for adenosine and/or a pressure wire. Seamless integration in the healthcare IT environment and an easy connection with the DICOM network. Innovative QFR® analysis, a measure of the functional significance of lesions, without the need for adenosine and/or a pressure wire.
Learn more
Infervision
Infervision is a leading AI medical technology company established in 2016, focusing on improving multidisciplinary services and operations with AI. They offer cutting-edge AI products that support medical professionals in all areas, from disease screening and diagnosis to intervention and treatment, patient management, and medical research. Their solutions include InferRead CT Lung for lung nodule detection from chest CT, InferRead DR Chest for detecting chest abnormalities from chest X-rays, InferRead CT Coronary for identifying coronary artery stenosis in coronary CTA, InferRead CT Stroke for triaging hemorrhage from brain CT, InferRead CT Bone for identifying chest fractures from chest CT, and InferRead CT Pneumonia for identifying and triaging pneumonia from chest CT. Additionally, they offer InferOperate for 3D reconstruction in thoracic, liver, and urological surgeries, InferCare for patient management and image follow-up, and InferScholar as an AI-enabled medical research tool.
Learn more
Elucid
Deliver personalized patient care with the only histologically validated, objective, and quantitative CTA-based arterial analysis software. Utilize ground-truth histology to visualize the source of myocardial ischemia and inform heart attack and stroke risk. Heart attack and stroke are primarily caused by non-obstructive, but unstable plaque in the arteries that goes undiagnosed and untreated. Current non-invasive testing cannot visualize the biology deep inside artery walls where heart disease develops. Elucid is harnessing scientific imaging and artificial intelligence to enable quick, accurate, noninvasive diagnoses and precise treatment of cardiovascular disease to enable better patient outcomes. Assess plaque composition with histology-validated software. Quantify heart attack and stroke risk with greater accuracy. Visualize a comprehensive and objective view of arterial disease to enable personalized treatment plans before a patient ever enters the hospital.
Learn more
Artrya
Artrya partners with clinics receiving chest pain patients to deliver new models of cardiovascular care based on AI. Easily integrate plaque features of high prognostic value into the evaluation of coronary artery disease. Rapid assessment of chest pain patients in emergency and primary care settings. We see a world where communities do not have to be plagued by a high rate of a heart attack. AI-driven insights into the type and volume of arterial plaque detected through coronary computed tomography angiography (CCTA) facilitate the accurate stratification of chest pain patients within minutes. Quickly determine patients with minimal to zero coronary artery disease with the confidence there are no underlying plaque features that could cause future major adverse cardiac events. Catch the early warning signs of a potential heart attack. Effectively rule in at-risk patients with acute or atypical chest pain who warrant further investigation and therapy.
Learn more
Integrations
No integrations listed.
Company Information
HeartFlow
Founded: 2010
United States
www.heartflow.com
Videos and Screen Captures
Other Useful Business Software
Our Free Plans just got better! | Auth0
You asked, we delivered! Auth0 is excited to expand our Free and Paid plans to include more options so you can focus on building, deploying, and scaling applications without having to worry about your security. Auth0 now, thank yourself later.
Product Details
Platforms Supported
Cloud
Training
Documentation
Live Online
In Person
Videos
Support
Phone Support
Online
